Rosid 150 mg (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
KOLON Pharmaceutical Co., Ltd.
MFDS item code 199200629 · Notified 1992.09.22
This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers and reflux), prevention of Mendelson syndrome, and improvement of gastric mucosal lesions
This medication is effective for gastrointestinal diseases such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also used to prevent Mendelson's syndrome before surgery and to treat ulcers caused by NSAID use. It helps improve gastric mucosal lesions in conditions such as acute gastritis, chronic gastritis exacerbation, and upper gastrointestinal bleeding. It effectively relieves symptoms of heartburn and acid reflux caused by excessive stomach acid, especially in liquid form for relieving reflux symptoms. This way, it is utilized in various gastrointestinal-related disorders to improve patients' symptoms.
Administer ranitidine 150 mg per dose orally 2 times daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine per dose orally 2 times daily, or 300 mg once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 300 mg per dose 2 times daily, in the morning and at bedtime. The same dosage and administration apply to concomitant treatment of ulcers caused by nonsteroidal anti-inflammatory drugs or for prevention of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Ulcers usually heal within 4 weeks, and conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medicine per dose 2 times daily for 8 weeks, or 300 mg once daily at bedtime. The dose may be increased to 150 mg per dose 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 150 mg of this medicine per dose 3 times daily, and increase the dose as needed. In severe cases, up to 6 g daily may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and administer 150 mg of this medicine per dose 2 times daily. 5) Premedication (prevention of Mendelson's syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. It is also preferable to administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medicine per dose once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Since hemodialysis reduces the blood concentration of the drug, readjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.
For ages 8 〜 18 years, 150 mg per dose (2 mg per kg of body weight) may be administered up to 2 times daily. For patients aged 12 years or older, administer 75 mg per dose orally 2 times daily (liquid formulation only).
This medication should not be used in patients who have had allergic reactions to any of its ingredients. It should also be avoided in patients with a history of acute porphyria as it may worsen symptoms. For patients with decreased kidney function, the concentration of this medication may increase, so dosages should be reduced or intervals between doses extended. Caution is also warranted for patients with impaired liver function. Patients with a history of drug allergies should be administered with care. Elderly patients should be cautious due to an increased risk of side effects from decreased body function. Patients taking non-steroidal anti-inflammatory drugs, particularly elderly patients or those with a history of peptic ulcers, will require regular monitoring. As this medication can mask symptoms of gastric cancer, patients with gastric ulcers or new dyspeptic symptoms in middle age or older should undergo evaluation for malignancy prior to use. Patients with Helicobacter pylori-infected gastric and duodenal ulcers require eradication therapy. Rarely, serious allergic reactions such as anaphylactic shock may occur; if any unusual symptoms arise during treatment, it should be discontinued immediately and appropriate treatment provided. Treatment should be stopped if symptoms of hypersensitivity such as rash, hives, fever, or difficulty breathing develop. If blood disorders emerge, such as fatigue, bleeding, or fever, a blood test should be conducted and necessary measures taken. If hepatic dysfunction symptoms arise, medication should be stopped immediately, and a physician should be consulted. There have been reports of rare occurrences of arrhythmias or vasculitis, so caution is advised if symptoms occur. Gastrointestinal symptoms such as constipation, nausea, or abdominal pain may develop; if discomfort persists, medical attention should be sought. If neurological symptoms such as dizziness, drowsiness, or headache occur, driving or operating hazardous machinery should be avoided. Muscle pain or joint pain, and rarely severe muscle damage, may occur, necessitating discontinuation of the medication if these symptoms arise. Skin rash or hair loss may occur. This medication may interact with other drugs, so it is essential to inform healthcare providers of any concurrently taken medications. Women who are pregnant or may become pregnant should use this medication cautiously, and nursing mothers should consult a physician before use. Safety in children has not been sufficiently established, so caution is advised. Elderly patients may experience increased drug concentration due to decreased kidney function; thus, dosage adjustments may be necessary. This medication may give false positive results in some tests; a discussion with healthcare providers about testing methods is warranted. In case of overdose, appropriate treatments such as vomiting or gastric lavage may be needed, and in severe cases, hemodialysis may be necessary. Store the medication out of reach of children, and do not transfer it to another container for safety. This medication reduces gastric acid secretion, which may promote bacterial growth in the stomach; therefore, long-term use may necessitate ophthalmological examinations.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container at dry room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the effectiveness of the medication over time.
White round film-coated tablet
100 tablets (10 tablets/Alu-Alu X 10)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
KOLON Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.